Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02634645 · ClinicalTrials.gov registry record
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
A clinical trial of Esophageal Cancer and Barrett's Esophagus, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 4
- Study locations
NCT02634645: Recruiting study of Esophageal Cancer and Barrett's Esophagus, sponsored by University of Colorado, Denver.
NCT02634645 is a study of Esophageal Cancer and Barrett's Esophagus that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 5,000 participants, above the 458-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (992% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02634645, a study of Esophageal Cancer and Barrett's Esophagus, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).
Primary Outcome
A systematic, prospective collection of data from a large cohort of patients with BE and EAC undergoing EET will provide useful data in effort to improve overall patient outcomes.
Conditions Studied
Interventions
- DRUG Chemotherapy
- RADIATION Radiation
- PROCEDURE Esophagectomy
- PROCEDURE Endoscopic eradication therapies (EET)
Study Locations (4)
California
- UCLA Medical Center - Los Angeles
Florida
- Moffitt Cancer Center - Tampa
Illinois
- Northwestern Memorial Hospital - Chicago
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2015-01 |
| Est. Completion | 2027-01 |
What NCT02634645 shows while recruiting
NCT02634645 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 458-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (992% higher).
The record links to 2 conditions, with Esophageal Cancer appearing as the primary indexed condition, and to 4 interventions - of which Chemotherapy is the first listed.
NCT02634645 reports a single indexed study location in California, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT02634645 about?
NCT02634645 is a clinical study titled "TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)". A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).
What is the current status of trial NCT02634645?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2015-01. Estimated completion is 2027-01.
What conditions does trial NCT02634645 study?
This clinical trial studies the following conditions: Esophageal Cancer, Barrett's Esophagus.
What interventions are being tested in trial NCT02634645?
The interventions under investigation include: Chemotherapy (DRUG), Radiation (RADIATION), Esophagectomy (PROCEDURE), Endoscopic eradication therapies (EET) (PROCEDURE).
Who is sponsoring clinical trial NCT02634645?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02634645 being conducted?
This trial has 4 study locations across California, Florida, Illinois, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02634645's enrollment target sits among peer trials
5,000 4th of 123 higher than 119 of 123 other Esophageal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Esophageal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Registry for Esophageal and Gastroesophageal Junction Cancer
RECRUITING
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
Retrospective Review of Esophageal Cancer at MSKCC
RECRUITING
-
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
RECRUITING · Phase 1
-
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia